The objective of the trust is to obtain capital growth. In pursuing its objective, the scheme will invest predominantly in transferable securities of UK listed and/or UK domiciled companies.
Name | % Net Assets |
---|---|
BP Plc | 8.4% |
HSBC Holdings Plc | 8.0% |
Royal Dutch Shell B | 4.2% |
Tesco Plc | 3.9% |
BG Group Plc | 3.4% |
Imperial Tobacco Group Plc | 3.3% |
Glaxosmithkline Plc | 3.1% |
Astrazeneca Ord 25P | 3.0% |
British American Tobacco Plc | 3.0% |
Vodafone Group Public | 3.0% |
Key | % Net Assets |
---|---|
BP Plc | 8.4% |
HSBC Holdings Plc | 8.0% |
Royal Dutch Shell B | 4.2% |
Tesco Plc | 3.9% |
Other | 75.5% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 01/07/1982 |
---|---|
Fund Manager | n/a |
TER | 1.61 (10-Mar-2010) |
Minimum Investment | |
---|---|
Initial | 500 |
Additional | n/a |
Savings | 25 |
Charges | |
---|---|
Initial | 5.25% |
Annual Mang't | 1.45% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.08 |
You are here: research